Journals / Marmara Medical Journal / 2023 / Cilt: 36 Sayı: 2

Is subclinical hypothyroidism a risk factor for gestational diabetes mellitus?

Pages
230–234
Publication Date
2023-05-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Risk scales that include the first trimester TSH level should be established for the development of GDM.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Gestational diabetes mellitus is characterized by increased blood sugar that first appears during pregnancy.
📊
Key Findings & Data:From the patient records, the first 250 pregnant women who applied to our hospital for screening at 20-24 weeks and had glucose tolerance tests were included in our study.
💡
Conclusion & Impact:Risk scales that include the first trimester TSH level should be established for the development of GDM.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Gestational diabetes mellitus · Subclinical hypothyroidism · Thyroid Stimulating Hormone

Abstract

Objective: Gestational diabetes mellitus is characterized by increased blood sugar that first appears during pregnancy. Multiple articles have described a relationship between hypothyroidism/subclinical hypothyroidism (SCH) and a rise in the risk of concomitant pregnancy complications, including gestational diabetes mellitus (GDM), but the effect of SCH on pregnancy is uncertain in the literature. We clarified the contribution of SCH to GDM development. Patients and Methods: We conducted a retrospective study. From the patient records, the first 250 pregnant women who applied to our hospital for screening at 20-24 weeks and had glucose tolerance tests were included in our study. Retrospectively, all these pregnant women’s first-trimester thyroid-stimulating hormone (TSH) levels were recorded. We created two groups according to the oral glucose tolerance test (OGTT) results: a case group diagnosed with GDM and a control group with average blood glucose. Their first-trimester TSH levels were compared between the two groups and defined whether they had euthyroid, subclinical hypothyroidism (TSH=2.5- 5.5mIU/L) or overt hypothyroidism (TSH >5.5). Results: We diagnosed 37 of 191 patients (19.4%) with GDM. When we checked the case and control groups, the mean TSH of the GDM group was 1.8 mIU/L, and the control group was 1.7 mIU/L, but the difference was not statistically significant (p=0.121). 24.32% (n=9) of 37 pregnant women with GDM were diagnosed with subclinical hypothyroidism/hypothyroidism; this rate was as low as 14.93% (n=28) in the non-GDM group, but no statistical difference was found (p=0.21). Conclusion: It can be predicted that other accompanying factors may be the primary determinant in the development of GDM rather than subclinical hypothyroidism. Risk scales that include the first trimester TSH level should be established for the development of GDM.

🔖

Cite This Article

SELIM, H. S., SENGUL, M. (2023). Is subclinical hypothyroidism a risk factor for gestational diabetes mellitus?. Marmara Medical Journal, Cilt: 36 Sayı: 2, 230–234. https://ajindex.com/articles/941429

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Mack LR, Tomich PG. Gestational Diabetes: Diagnosis, Classification, and Clinical Care. Obstet Gynecol Clin North Am 2017;44:207-17. doi: 10.1016/j.ogc.2017.02.002 [2] Alfadhli EM. Gestational diabetes mellitus. Saudi Med J 2015;36:399-406. doi: 10.15537/smj.2015.4.10307 [3] Zhang C, Rawal S, Chong YS. Risk factors for gestational diabetes: is prevention possible? Diabetologia 2016;59:1385- 90. doi: 10.1007/s00125.016.3979-3 [4] Giannakou K, Evangelou E, Yiallouros P, et al. Risk factors for gestational diabetes: An umbrella review of meta-analyses of observational studies. PLoS One 2019;14:e0215372. doi: 10.1371/journal.pone.0215372 [5] Maraka S, Ospina NM, O’Keeffe DT, et al. Subclinical hypothyroidism in pregnancy: a systematic review and metaanalysis. Thyroid 2016;26:580-90. doi: 10.1089/thy.2015.0418 [6] Tudela CM, Casey BM, McIntire DD, Cunningham FG. Relationship of subclinical thyroid disease to the incidence of gestational diabetes. Obstet Gynecol 2012;119:983-8. doi: 10.1097/AOG.0b013e318250aeeb
  2. Chen LM, Du WJ, Dai J, et al. Effects of subclinical hypothyroidism on maternal and perinatal outcomes during pregnancy: a single-center cohort study of a Chinese population. PloS One 2014;9:e109364. doi:10.1371/journal. pone.0109364 [8] Nelson DB, Casey BM, McIntire DD, Cunningham FG. Subsequent pregnancy outcomes in women previously diagnosed with subclinical hypothyroidism. Am J Perinatol. 2014;31:77-84. doi: 10.1055/s-0033.133.4457. [9] [Guideline] American Diabetes Association
  3. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020. Diabetes Care 2020;43 (Suppl 1): S14-S31
  4. Cleary-Goldman J, Malone FD, Lambert-Messerlian G, et al. Maternal thyroid hypofunction, and pregnancy outcome. Obstet. Gynecol 2008;112:85-92. doi:10.1097/ AOG.0b013e3181788dd7 [11] Stagnaro-Green A, Abalovich M, Alexander E, et al. American Thyroid Association Taskforce on Thyroid Disease During Pregnancy and Postpartum. Guidelines of the American Thyroid Association for diagnosing and managing thyroid disease during pregnancy and postpartum. Thyroid 2011;21:1081-125. doi: 10.1089/thy.2011.0087 [12] Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid 2017;27:315-89. doi: 10.1089/ thy.2016.0457 [13] Veltri F, Belhomme J, Kleynen P, et al. Maternal thyroid parameters in pregnant women with differ